XML 42 R61.htm IDEA: XBRL DOCUMENT v3.20.1
Investments (Schedule Of Fair Value Method Investments, Balance Sheets And Income Statements) (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Assets                        
Cash and cash equivalents $ 31,422 [1]       $ 34,397 [1]       $ 31,422 [1] $ 34,397 [1] $ 36,491 $ 29,511
Net property, plant and equipment 242,890       228,369       242,890 228,369    
Patents 22,636       36,295       22,636 36,295    
Other assets 4,733       4,012       4,733 4,012    
Total assets [1] 712,668       707,373       712,668 707,373    
Liabilities and Shareholders’ Equity                        
Other noncurrent liabilities 42,000       101,500       42,000 101,500    
Equity 376,749       354,857       376,749 354,857 343,780 $ 310,783
Total liabilities and shareholders’ equity 712,668       707,373       712,668 707,373    
Revenues & Expenses:                        
Income tax (expense) benefit [2]                 (9,913) (11,526) 53,163  
Net income $ (3,135) $ 17,133 $ 14,477 $ 19,785 $ 26,157 $ (34,201) $ 14,722 $ 18,165 $ 48,259 $ 24,842 $ 38,251  
[1] Information on exports and foreign operations are provided on the previous page. Cash and cash equivalents includes funds held in locations outside the U.S. of $23.0 million and $31.1 million at December 31, 2019 and 2018, respectively. Export sales relate almost entirely to PE Films. Operations outside the U.S. in The Netherlands, Hungary, China and India also relate to PE Films. Operations in Brazil are primarily related to Flexible Packaging Films, but also include PE Films operations. Sales from locations in The Netherlands and Hungary are primarily to customers located in Europe. Sales from locations in China (Guangzhou and Shanghai) are primarily to customers located in China, but also include other customers in Asia.
[2] See Notes 1, 3, 4 and 17 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains or losses from sale of assets, gains or losses on an investment accounted for under the fair value method and other items.